Brody Slostad, Vinesh Appadurai, Akhil Narang, Sarah Hale, Susan Lehrer, Aakash Bavishi, Adrienne Kline, Ike Okwuosa, Madeline Jankowski, Richard Weinberg, Mayank Kansal, James D Thomas, Sanjiv Shah
AIMS: Differentiating cardiac amyloidosis (CA) subtypes is important considering the significantly different therapies for transthyretin (ATTR)-CA and light chain (AL)-CA. Therefore, an echocardiographic method to distinguish ATTR-CA from AL-CA would provide significant value. We assessed a novel echocardiographic pixel intensity method to quantify myocardial calcification to differentiate ATTR-CA from phenocopies of CA and from AL-CA, specifically. METHODS AND RESULTS: 167 patients with ATTR-CA (n=53), AL-CA (n=32), hypertrophic cardiomyopathy (n=37), and advanced chronic kidney disease (n=45) were retrospectively evaluated...
April 6, 2024: European Heart Journal Cardiovascular Imaging